4. The subject must have a current CMV infection refractory or resistant to treatment. Refractory is defined as failure to have greater than (>)1 log10 decrease in CMV viral load within minimum of 2 weeks of treatment with ganciclovir, valganciclovir, foscarnet or cidofovir .